Clinical Trials Logo
  1. Home
  2. Amyloid Cardiomyopathy
  3. NCT05699044

Screening of ATTRwt in Patient With Advanced AV-Block Undergoing Pacemaker Implantation — ATTRAB  

Amyloid Cardiomyopathy Clinical Trial

Official title:
Prevalence, Characteristics and Prognosis of Transthyretin Amyloidosis in Patients With New-onset Advanced AV-block - A National Screening Study

Clinical Trial Summary

The investigators will nationally investigate the prevalence of Transthyretin Amyloidosis wildtype (ATTRwt) in patients of ≥ 65 years with left ventricular hypertrophy who present with high degree atrioventricular block (AV-block) and are admitted for pacemaker implantation. The investigators aim to characterize the group of patients with positive screening of ATTR and compare the ATTRwt disease stage at time of diagnosis for patients identified with ATTR at screening with a control group of routinely clinically diagnosed ATTRwt patients.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05699044
Study type Observational
Source Aarhus University Hospital Skejby
Contact Jens Skov, MD
Phone 2074381
Email jesmds@rm.dk
Status Recruiting
Phase
Start date October 1, 2022
Completion date October 1, 2025
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04738266 - Unmasking the Prevalence of AC in an Unselected Echocardiographic Population
Recruiting NCT05797857 - Exercise Training in Transthyretin Cardiac Amyloidosis N/A
Completed NCT03860935 - Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy Phase 3
Recruiting NCT03397810 - Effect of Radiotherapy on ATTR Cardiac Amyloidosis : a Proof of Concept Study N/A
Recruiting NCT05795400 - Administration of the SGLT-2 Inhibitor Dapagliflozin in the Patients With Amyloid Cardiomyopathy N/A
Recruiting NCT06048601 - 18F-florbetaben PET-CT to Non-invasively Diagnose Cardiac AL Amyloidosis N/A
Recruiting NCT06328075 - Artificial Intelligence to Assist the Echocardiographic Identification of Transthyretin Cardiac Amyloidosis
Recruiting NCT05103943 - Amyloidosis TTR Flow Reserve Evaluation N/A
Recruiting NCT04776824 - Swiss Cardiac Amyloidosis REgistry (Swiss-CARE)
Recruiting NCT06261216 - Association Between Lifetime Physical Activity and Exercise and the Development of Wild-type Transthyretin Amyloid Cardiomyopathy
Active, not recruiting NCT03431896 - Monitoring of Early Disease Progression in Hereditary Transthyretin Amyloidosis
Active, not recruiting NCT03536767 - Open-Label Study of AG10 in Patients With Cardiomyopathy Phase 2
Active, not recruiting NCT05452850 - Longitudinal Changes in Left and Right Ventricular Global Strain After Chemotherapy in Cardiac Light Chain Amyloidosis
Active, not recruiting NCT05448716 - Left Atrial Strain and Supraventricular Arrhythmia Burden in Cardiac Light Chain Amyloidosis Following Chemotherapy